Overall Status

Completed (37)

Terminated (6)

Unknown status (6)

Withdrawn (3)

Recruiting (1)

Phase

phase 2 (18)

phase 1 (13)

n/a (6)

phase 4 (5)

phase 3 (4)

early phase 1 (3)

phase 1/phase 2 (2)

Collaborator

National Institute on Drug Abuse (NIDA) (21)

National Institutes of Health (NIH) (2)

Creare, Inc. (1)

Janssen, LP (1)

Portland VA Medical Center (1)

Stanley Medical Research Institute (1)

University of North Texas Health Science Center (1)

VA Office of Research and Development (1)

Study Documents

Intervention Type

drug (43)

other (5)

behavioral (3)

device (3)

dietary supplement (1)

Funder Type

Other (46)

NIH (5)

Industry (1)

U.S. Fed (1)

Study Type

Interventional (51)

Observational (2)

methamphetamine dependence

Showing 51 - 53 of 53

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Methamphetamine Dependence Trial in Little Rock (Quetiapine)

Terminated

Methamphetamine Dependence

Quetiapine

Little Rock, Arkansas

University of Arkansas for Medical Sciences

Jul 12, 2010

Methamphetamine Dependence Trial in Seattle (long-acting injectable risperidone)

Completed

Methamphetamine Dependence

long-acting injectable risperidone

Seattle, Washington

VA Puget Sound Health Care System, Addictions Treatment Center

Jan 3, 2008

Bipolar Disorder, Cocaine Dependence, Methamphetamine Dependence Trial in Dallas, Fort Worth (quetiapine, risperidone)

Completed

Bipolar Disorder
+2 more

quetiapine, risperidone

Dallas, Texas
+1 more

Jan 3, 2008